DMD and sarcoma: Indeed, dystrophin has known oncosuppressor functions, although not completely explored, as recently pinpointed for its role in keeping genome stability via, at least in part, ROS release (Jelinkova et al., 2019) and its capacity to inhibit myogenic cell migration in sarcoma (Wang et al., 2014).